Home
Drugs
Cemiplimab
Clinical Trials

Clinical Trials Related to Cemiplimab

Related studies linked through entity extraction aliases.

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Expanded Access Use of Cemiplimab in Patients With Solid Tumors

Status: APPROVED_FOR_MARKETING
Phase: N/A

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

Status: RECRUITING
Phase: PHASE2

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Status: RECRUITING
Phase: PHASE1/PHASE2

Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

Status: RECRUITING
Phase: PHASE1/PHASE2

Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies

Status: TERMINATED
Phase: PHASE1

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Status: RECRUITING
Phase: PHASE1

The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Status: SUSPENDED
Phase: PHASE2

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Deep sequencIng in Cutaneous Squamous CEll caRciNomas

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

Status: WITHDRAWN
Phase: PHASE2

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2/PHASE3

A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2/PHASE3

A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer.

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2